Not applicableTemporarily pausedNCT05233007What this trial is testingUpper GI Serial Tumour BiopsiesWho this might be right forOesophageal CancerGastric Cancer The Christie NHS Foundation Trust 300
Testing effectiveness (Phase 2)WithdrawnNCT06690281What this trial is testingA Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal MalignanciesWho this might be right forGastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04989387What this trial is testingStudy of INCA 0186 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsSquamous Cell Carcinoma of the Head and Neck (SCCHN)Gastrointestinal (GI) Malignancies Incyte Corporation 57
Not applicableActive Not RecruitingNCT06642506What this trial is testingOncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal CarcinomaWho this might be right forEsophagus AdenocarcinomaEsophagus CancerMetabolome+5 more Ludwig-Maximilians - University of Munich 20
Early research (Phase 1)Study completedNCT00666991What this trial is testingPharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal CancersWho this might be right forPeritoneal Neoplasms CritiTech, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00019474What this trial is testingCombination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more Montefiore Medical Center 60
Early research (Phase 1)Active Not RecruitingNCT04535401What this trial is testingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesWho this might be right forAdvanced Colorectal CarcinomaAdvanced Digestive System CarcinomaAdvanced Gastric Carcinoma+11 more National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Ended earlyNCT01886287What this trial is testingP:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid SyndromeWho this might be right forNeuroendocrine Carcinoma H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT02575300What this trial is testingPhase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsWho this might be right forCarcinoid TumorsPancreatic NET H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02102022What this trial is testingPh 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaWho this might be right forAdvanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more Polaris Group 140
Testing effectiveness (Phase 2)Study completedNCT01264705What this trial is testingStudy of Bavituximab and Sorafenib In Patients With Advanced Liver CancerWho this might be right forHepatocellular CarcinomaLiver Cancer University of Texas Southwestern Medical Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT03539822What this trial is testingCabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal MalignanciesWho this might be right forGastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more Anwaar Saeed 117
Early research (Phase 1)Looking for participantsNCT07229313What this trial is testingKIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvance Solid Tumors Kivu Bioscience Inc. 76
Not applicableStudy completedNCT01249859What this trial is testingPrognosis of Signet Ring Cells in Upper Digestive NeoplasmsWho this might be right forSignet Ring Cell CarcinomaStomach DiseaseOesophagus+2 more University Hospital, Lille 2,500
Testing effectiveness (Phase 2)Ended earlyNCT03287947What this trial is testingLCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal CarcinomaWho this might be right forAppendix Cancer Wake Forest University Health Sciences 5
Not applicableLooking for participantsNCT06715839What this trial is testingTarget-specific immunoPET Imaging of Digestive System CarcinomaWho this might be right forMalignancyDigestive CancerDigestive System Neoplasm+12 more RenJi Hospital 400
Not applicableActive Not RecruitingNCT04596384What this trial is testingHome Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal SurgeryWho this might be right forDigestive System CarcinomaGenitourinary System CarcinomaMalignant Female Reproductive System Neoplasm+1 more City of Hope Medical Center 398
Testing effectiveness (Phase 2)UnknownNCT05030246What this trial is testingTrial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal CancerWho this might be right forRefractory Metastatic Digestive System CarcinomaPrimary Peritoneal Cancer Peking University 72
Early research (Phase 1)Study completedNCT01420874What this trial is testingAnti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)Who this might be right forColorectal CancerCancer of PancreasPancreatic Neoplasm+5 more Barbara Ann Karmanos Cancer Institute 15
Not applicableActive Not RecruitingNCT04560712What this trial is testingAcupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing SurgeryWho this might be right forResectable Colorectal CarcinomaResectable Digestive System CarcinomaResectable Pancreatic Carcinoma M.D. Anderson Cancer Center 70